
Mayo Clinic/LinkedIn
Aug 10, 2025, 06:46
First U.S. Patient Receives Novel Radioactive Breast Cancer Treatment at Mayo Clinic
Mayo Clinic shared a post on LinkedIn:
“Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial.
The principal investigator at Mayo Clinic is Geoffrey Johnson, M.D., Ph.D., a professor of radiology and a leader in radiopharmaceutical therapies. He says these are innovative cancer treatments that use radioactive medicines designed to target and kill cancer cells with high precision.”
More Posts Featuring Mayo Clinic.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 10, 2025, 06:46
Aug 10, 2025, 06:33
Aug 10, 2025, 06:25
Aug 10, 2025, 06:10
Aug 10, 2025, 06:05
Aug 10, 2025, 05:10
Aug 10, 2025, 04:25
Aug 10, 2025, 02:08